Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. IO Biotech ( (IOBT)) has shared an ...
CHENGDU, China, Sept. 22, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that a new drug application (NDA) for the Company's small molecule rearranged ...
India's Bharat Biotech has sought emergency-use authorization from the Indian drug regulator for its COVID-19 vaccine, a senior government official said on Monday.
Seres Therapeutics is laying off a quarter of its workforce as the microbiome biopharma conserves resources to take its bloodstream infection preventive treatment into phase 2. The Cambridge, ...
Actuate Therapeutics, Inc. (ACTU) announced on Monday that it has amended its application to the U.S. Food and Drug Administration (FDA) for its lead investigational drug Elraglusib in the treatment ...
At BioConnect 3.0, experts emphasized the need for a dedicated biotech policy in Kerala to harness its potential in the life ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Rome Therapeutics is on the ropes, with the preclinical biotech planning layoffs for the end of the month, evaluating strategic options and ditching its physical headquarters to go entirely virtual, a ...
Arsenal Biosciences, a biotech startup based in South San Francisco, is laying off about half of its workers just a year after scoring a $325 million funding round. The cell therapy company is laying ...
Oct 1 (Reuters) - Biotechnology firm Galapagos' (GLPG.AS), opens new tab board has received non-binding offers from several groups, mainly comprised of financial investors, for its cell therapy ...
SINGAPORE: United States retail giant Target on Sep 24 initiated opposition proceedings against Singapore fashion brand Aupen's trademark registration application in the country. According to a notice ...
Bristol Myers Squibb is exiting the first U.S.-China pharmaceutical joint venture. Kalexo Bio and Ollin Biosciences have launched with big venture capital backers and Chinese assets. Roche and Johnson ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback